MedAvail Overview

  • Founded
  • 2012
  • Status
  • Public
  • Employees
  • 224
  • Stock Symbol
  • MDVL
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $14.00
  • (As of Tuesday Closing)

MedAvail General Information


MedAvail Holdings Inc is focused on the discovery, development and commercialization of advanced nutrition products that improve muscle health and performance.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare Services
Other Healthcare Technology Systems
Stock Exchange
Primary Office
  • 6665 Millcreek Drive
  • Unit 1
  • Mississauga, Ontario L5N 5M4
  • Canada
+1 (905) 000-0000

MedAvail Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MedAvail Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$14.00 $14.00 $9.00 - $20.79 $455M 32.5M 35K -$4.80

MedAvail Financials Summary

In Thousands,
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 392,700 476,618
Revenue 16,583 13,968 3,771
EBITDA (27,668) (23,807) (19,202)
Net Income (30,572) (26,810) (21,533)
Total Assets 59,538 69,331 18,003
Total Debt 3,393 3,477 13,567
Public Fundamental Data provided by Morningstar, Inc. disclaimer

MedAvail Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MedAvail‘s full profile, request access.

Request a free trial

MedAvail Executive Team (20)

Name Title Board Seat Contact Info
Edwin Kilroy Ph.D Chief Executive Officer & Board Member
Joan O'Rourke President
Ryan Ferguson Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Will Misloski Chief Marketing Officer, Marketing
Trina Lindsell Director of Client Relations
You’re viewing 5 of 20 executive team members. Get the full list »

MedAvail Board Members (5)

Name Representing Role Since
Edwin Kilroy Ph.D MedAvail Chief Executive Officer & Board Member 000 0000
Frank Litvack MD Pura Vida Investments Board Member 000 0000
Gerald Gradwell MedAvail Board Member 000 0000
Glenn Stettin MD Express Scripts Board Member 000 0000
Helen Ciesielski Lewis & Clark Ventures Board Member 000 0000
To view MedAvail’s complete board members history, request access »

MedAvail Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MedAvail Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore MedAvail‘s full profile, request access.

Request a free trial

MedAvail Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 0000 00000000 17-Nov-2020 000000000000000000 Biotechnology
To view MedAvail’s complete acquisitions history, request access »